Drug resistance in Giardia: clinical versus laboratory isolates

Drug Resistance Updates

Volumn 1, Issue 3, 1998, Pages 166-168

  Upcroft, Peter ^a  

^a QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0001312676     PISSN: 13687646     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1368-7646(98)80035-6     Document Type: Review

References (34)

1. Marshall M.M., Naumovitz D., Ortega Y., and Sterling C.R. Waterborne protozoan pathogens. Clin Microbiol Rev 10 (1997) 67-85
2. Farthing M.J.G. Giardiasis. Gastroenterol Clinics North Am 25 (1996) 493-515
3. Desenclos J.C., Zergabachew A., Desmoulins B., et al. Clinical, microbiological and antibiotic susceptibility patterns of diarrhoea in Korem, Ethiopia. J Trop Med Hyg 91 (1988) 296-301
4. Yung A.P., and Ruff T.A. Travel medicine 2. Upon return. Med J Aust 160 (1994) 206-212
5. Boreham P.F.L. The current status of chemotherapy for giardiasis. In: Thompson R., Reynoldson J.A., and Lymbery A.J. (Eds). Giardia: from molecules to disease (1994), CAB International, Wallingford 317-328
6. Hall A., and Nahar Q. Albendazole as a treatment for infections with Giardia duodenalis in children in Bangladesh. Trans R Soc Trop Med Hyg 87 (1993) 84-86
7. Boreham P.F.L., Phillips R.E., and Shepherd R.W. Altered uptake of metronidazole in vitro by stocks of Giardia intestinalis with different drug sensitivities. Trans R Soc Trop Med Hyg 82 (1988) 104-106
8. Zaat J.O., Mank T.G., and Assendelft W.J. A systematic review on the treatment of giardiasis. Trop Med Int Health 2 (1997) 63-82
9. Upcroft J.A., and Upcroft P. Drug resistance and Giardia. Parasitol Today 9 (1993) 187-190
10. Townson S.M., Boreham P.F.L., Upcroft P., and Upcroft J.A. Resistance to the nitroheterocyclic drugs. Acta Trop 56 (1994) 173-194
11. Townson S.M., Hanson G.R., Upcroft J.A., and Upcroft P. A purified ferredoxin from Giardia duodenalis. Eur J Biochem 220 (1994) 439-446
12. Townson S.M., Upcroft J.A., and Upcroft P. Characterisation and purification of pyruvate:ferredoxin oxidoredutase from Giardia duodenalis. Mol Biochem Parasitol 79 (1996) 183-193
13. 2O-producing NADH oxidase from the protozoan parasite Giardia duodenalis. Eur J Biochem 241 (1996) 155-161
14. Upcroft J.A., Campbell R.W., and Upcroft P. Quinacrine-resistant Giardia duodenalis. Parasitology 112 (1996) 309-313
15. Upcroft J., Mitchell R., Chen N., and Upcroft P. Albendazole resistance in Giardia is correlated with cytoskeletal changes but not with a mutation at amino acid 200 in β-tubulin. Microb Drug Resis 2 (1996) 303-308
16. Brown D.M., Upcroft J.A., Edwards M.R., and Upcroft P. Anaerobic bacterial metabolism in the ancient eukaryote Giardia duodenalis. Int J Parasitol 28 (1998) 149-164
17. Upcroft P. Multiple drug resistance in the pathogenic protozoa. Acta Tropica 56 (1994) 195-212
18. Nikaido H. Prevention of drug access to bacterial targets: permeability barriers and active efflux. Science 264 (1994) 382-388
19. Rasmussen B.A., Bush K., and Tally F.P. Antimicrobial resistance in anaerobes. Clin Infect Dis 24 Suppl. 1 (1997) S110-S120
20. Townson S.H., Laqua H., Upcroft P., et al. Induction of metronidazole and furazolidone resistance in Giardia. Trans R Soc Trop Med Hyg 86 (1992) 521-522
21. Foote S.J., and Cowman A.F. The mode of action and the mechanism of resistance to antimalarial drugs. Acta Tropica 56 (1994) 157-171
22. Rathod P., McErlean T., and Lee P.-C. Variations in frequencies of drug resistance in Plasmodium falciparum. Proc Natl Acad Sci USA 94 (1997) 9389-9393
23. Upcroft J.A., Healey A., Mitchell R.W., and Upcroft P. A new rDNA repeat unit in human Giardia. J Euk Microbiol 41 (1994) 639-642
24. Swarbrick A., Lim R.L.H., Upcroft J.A., and Stewart T.S. Nucleotide variation in the cytidine triphosphate synthetase gene of Giardia duodenalis. J Euk Microbiol 44 (1997) 531-534
25. Smith N.C., Bryant C., and Boreham P.F.L. Possible roles for pyruvate:ferredoxin oxidoreductase and thiol-dependent peroxidase and reductase activities in resistance to nitroheterocyclic drugs in Giardia intestinalis. Int J Parasitol 18 (1988) 991-997
26. Upcroft J.A., and Upcroft P. Two distinct varieties of Giardia in a mixed infection from a single human patient. J Euk Microbiol 41 (1994) 189-194
27. Upcroft J.A., Boreham P.F.L., Campbell R.W., et al. Biological and genetic analysis of a longitudinal collection of Giardia samples derived from humans. Acta Tropica 60 (1995) 35-46
28. Upcroft J.A., Healey A., Murray D.G., et al. A gene associated with cell division and drug resistance in Giardia intestinalis. Parasitology 104 (1992) 397-405
29. Chen N., Upcroft J.A., and Upcroft P. Physical map of a 2Mb chromosome of the intestinal protozoan parasite Giardia duodenalis. Chromosome Res 2 (1994) 307-313
30. Čerkasovová A., Novák J., Čerkasov J., et al. Metabolic properties of Trichomonas vaginalis resistant to metronidazole under anaerobic conditions. Acta Univers Carol - Biol 30 (1986) 505-512
31. Zhang Y. Life without KatG. Trends Microbiol 4 (1996) 415-416
32. Carlier J.-P., Sellier N., Rager M.-N., and Reysset G. Metabolism of a 5-nitroimidazole in susceptible and resistant isogenic strains of Bacteroides fragilis. Antimicrob Agents Chemother 41 (1997) 1495-1499
33. Banatvala N., Davies G.R., Abdi Y., et al. High prevalence of Helicobacter pylori metronidazole resistance in migrants to east London: relation with previous nitroimidazole exposure and gastroduodenal disease. Gut 35 (1994) 1562-1566
34. Lipsitch M., and Levin B.R. The population dynamics of antimicrobial chemotherapy. Antimicrob Agents Chemother 41 (1997) 363-373